TrudyRBakerMD

PubMed

• 72 citations
  Familial ovarian cancer. A report of 658 families from the Gilda Radner familial ovarian cancer registry 1981-1991
  M.Steven Piver, Trudy R. Baker, Mohannad F. Jishi, M R N Anita Sandecki, Yoshiaki Tsukada, Nachimuthu Natarajan, Curtis Mettlin, Cheryl A. Blake> ;Cancer. 2010 Aug 31
• 30 citations
  Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review.
  Alireza A. Shamshirsaz, Matthew Withiam-Leitch, Kunle Odunsi, Trudy R. Baker, Peter J. Frederick, Shashikant Lele> ;Gynecologic Oncology. 2007 Mar 1
• 18 citations
  Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
  K. Odunsi, V. Moneke, Jonathan Tammela, Sharad A. Ghamande, P. Seago, Deborah L. Driscoll, David Marchetti, Trudy R. Baker, Sashikant Lele> ;International Journal of Gynecological Cancer. 2004 Jul 1
• 32 citations
  Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.
  Sharad A. Ghamande, Shashikant Lele, David Marchetti, Trudy R. Baker, Kunle Odunsi> ;International Journal of Gynecological Cancer. 2003 Mar 1
• 33 citations
  Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer
  Gamal H. Eltabbakh, M.Steven Piver, Ronald E. Hempling, Fernando O. Recio, S.B. Lele, David L. Marchetti, Trudy R. Baker, Leslie E. Blumenson> ;Gynecologic Oncology. 1998 Sep 1
• 23 citations
  Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
  Terri L. Cornelison, Trudy R. Baker, Steven M. Piver, Deborah L. Driscoll> ;Gynecologic Oncology. 1995 Nov 1
• 23 citations
  Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sar...
  Ronald E. Hempling, Piver Ms, Trudy R. Baker> ;American Journal of Clinical Oncology. 1995 Aug 1
• 52 citations
  SEVERE RADIATION MORBIDITY IN CARCINOMA OF THE CERVIX: IMPACT OF PRETHERAPY SURGICAL STAGING AND PREVIOUS SURGERY
  Bruce A. Fine, Ronald E. Hempling, M.Steven Piver, Trudy R. Baker, Michael Mcauley, Deborah L. Driscoll> ;International Journal of Radiation Oncology, Biology, Physics. 1995 Feb 15
• 4 citations
  Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer : a pilot study
  Ronald E. Hempling, Piver Ms, Trudy R. Baker, Suraj Bakshi, S. S. H. Gilani> ;American Journal of Clinical Oncology. 1994 Aug 1
• 36 citations
  Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced o...
  Trudy R. Baker, M.Steven Piver, Ronald E. Hempling> ;Cancer. 1994 Jul 15
• 29 citations
  Etiology, biology, and epidemiology of ovarian cancer
  Trudy R. Baker, M.Steven Piver> ;Seminars in Surgical Oncology. 1994 Jul 1
• 5 citations
  Pregnancy coexisting with serous papillary adenocarcinoma involving both uterus and ovary.
  Bruce A. Fine, Trudy R. Baker, Ronald E. Hempling, Marilyn Intengan> ;Gynecologic Oncology. 1994 Jun 1
• 25 citations
  Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
  M.Steven Piver, Fernando O. Recio, Trudy R. Baker, B A Deborah Driscoll> ;Cancer. 1994 Mar 15
• 1 citations
  Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial ovarian cancer: results of a phase II trial.
  Ronald E. Hempling, Piver Ms, Trudy R. Baker, O'Neill Mullen C> ;European Journal of Gynaecological Oncology. 1994 Jan 1
• 4 citations
  Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer.
  Ronald E. Hempling, M. S. Piver, Nachimuthu Natarajan, Trudy R. Baker, J. M. Thompson, M. L. Hicks, C. Mettlin> ;Journal of Surgical Oncology. 1993 Sep 1
• 32 citations
  Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus
  M. L. Hicks, M.Steven Piver, Jeffrey L Puretz, Ronald E. Hempling, Trudy R. Baker, Michael Mcauley, Debra Walsh> ;International Journal of Radiation Oncology, Biology, Physics. 1993 Jul 15
• 14 citations
  A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma
  Peter G. Rose, M.Steven Piver, John H. Malfetano, Trudy R. Baker, Ronald E. Hempling, Fernando O. Recio> ;Cancer. 1993 Apr 1
• 3 citations
  Response to Taxol chemotherapy in resistant ovarian carcinoma.
  Trudy R. Baker, Piver Ms, Ronald E. Hempling> ;European Journal of Gynaecological Oncology. 1993 Jan 1
• 2 citations
  The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma.
  Trudy R. Baker, Piver Ms, Ronald E. Hempling> ;European Journal of Gynaecological Oncology. 1993 Jan 1
• 13 citations
  A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma.
  M.Steven Piver, Fernando O. Recio, Trudy R. Baker, Ronald E. Hempling> ;Gynecologic Oncology. 1992 Dec 1
• 26 citations
  Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.
  M.Steven Piver, John H. Malfetano, Trudy R. Baker, Ronald E. Hempling> ;Gynecologic Oncology. 1992 Sep 1
• 12 citations
  Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
  Piver Ms, James Fanning, Trudy R. Baker> ;American Journal of Clinical Oncology. 1991 Jun 1
• 25 citations
  Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
  Trudy R. Baker, Piver Ms, Haluk Caglar, Marion Piedmonte> ;American Journal of Clinical Oncology. 1991 Jun 1
• 12 citations
  Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report.
  M.Steven Piver, John Malfetano, Ronald E. Hempling, Trudy R. Baker, Deborah L. Driscoll> ;Gynecologic Oncology. 1990 Dec 1
• 8 citations
  Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemot...
  Piver Ms, Trudy R. Baker, Deborah L. Driscoll> ;European Journal of Gynaecological Oncology. 1990 Jan 1
• Join now to see all